Antithymocyte globulin and methotrexate therapy of severe or persistent cardiac allograft rejection
- 1 August 1995
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 60 (2) , 372-376
- https://doi.org/10.1016/0003-4975(95)00414-g
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Methotrexate and histologic hepatic abnormalities: A meta-analysisThe American Journal of Medicine, 1991
- A RANDOMIZED PROSPECTIVE COMPARISON OF MALG WITH OKT3 FOR RESCUE THERAPY OF ACUTE MYOCARDIAL REJECTIONTransplantation, 1991
- METHOTREXATE AS AN ADJUNCT IN THE TREATMENT OF PERSISTENT MILD CARDIAC ALLOGRAFT REJECTIONTransplantation, 1990
- SIX WEEKS OF CONTINUOUS INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE METHOTREXATE AS PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1990
- EFFICACY OF OKT3 RETREATMENT FOR REFRACTORY CARDIAC ALLOGRAFT REJECTIONTransplantation, 1989
- Cyclosporin A in Cardiac Transplantation: Medium-term Results in 62 PatientsThe Annals of Thoracic Surgery, 1988
- Heart Transplantation in the Cyclosporine EraThe Annals of Thoracic Surgery, 1988
- USE OF OKT3 MONOCLONAL ANTIBODY IN THE TREATMENT OF ACUTE CARDIAC ALLOGRAFT REJECTIONTransplantation, 1988
- Lymphocyte Subpopulation Monitoring in Cyclosporine-Treated Patients Following Heart TransplantationThe Annals of Thoracic Surgery, 1988
- Heart TransplantationPublished by American Medical Association (AMA) ,1984